78.27
1.54 (2.01%)
1.54 (2.01%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 1.54 | 2.01% | 78.27 | 76.73 | 78.43 | 77.07 | 76.73 | 11:25:55 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 16,154 | 1,692,238 | $ 77.43 | $ 131,028,807 | 10,134,126 | 65.25 - 92.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:25:55 | 41 | $ 78.27 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 195.04B | 2.52B | 2.52B | $ 46.84B | $ 9.66B | 3.81 | 19.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 14.56M | $ 2.26 | 2.92% | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 79.35 | 80.022 | 75.5392 | 77.94 | 6,888,947 | -1.08 | -1.36% |
| 1 Month | 74.96 | 80.022 | 73.572 | 76.78 | 9,802,584 | 3.31 | 4.42% |
| 3 Months | 82.82 | 84.75 | 73.572 | 78.50 | 10,667,558 | -4.55 | -5.49% |
| 6 Months | 89.73 | 92.0554 | 65.25 | 79.18 | 12,401,792 | -11.46 | -12.77% |
| 1 Year | 80.60 | 92.64 | 65.25 | 81.53 | 10,346,596 | -2.33 | -2.89% |
| 3 Years | 62.79 | 92.64 | 52.83 | 72.27 | 10,255,845 | 15.48 | 24.65% |
| 5 Years | 58.29 | 92.64 | 45.69 | 66.91 | 9,834,309 | 19.98 | 34.28% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
